Published in Hepatology on July 01, 1989
Liver transplantation (1). N Engl J Med (1989) 4.53
Prioritization and organ distribution for liver transplantation. JAMA (1994) 2.38
EU's new pharmacovigilance legislation: considerations for biosimilars. Drug Saf (2014) 2.12
Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis. Gut (2002) 1.98
The unfinished business of primary biliary cirrhosis. J Hepatol (2008) 1.56
Biochemical criteria at 1 year are not robust indicators of response to ursodeoxycholic acid in early primary biliary cirrhosis: results from a 29-year cohort study. Aliment Pharmacol Ther (2013) 1.56
Primary biliary cirrhosis. Semin Immunopathol (2009) 1.46
Characterisation of patients with primary biliary cirrhosis responding to long term ursodeoxycholic acid treatment. Gut (2000) 1.42
Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls. Hepatology (2008) 1.40
Fatigue in primary biliary cirrhosis. Gut (1998) 1.32
Primary biliary cirrhosis. Orphanet J Rare Dis (2008) 1.31
ELASTIC NET FOR COX'S PROPORTIONAL HAZARDS MODEL WITH A SOLUTION PATH ALGORITHM. Stat Sin (2012) 1.23
Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis. Surg Gynecol Obstet (1993) 1.21
Disease gravity and urgency of need as guidelines for liver allocation. Hepatology (1994) 1.16
Important predictor of mortality in patients with end-stage liver disease. Clin Mol Hepatol (2013) 1.15
Shrinkage Estimation of Varying Covariate Effects Based On Quantile Regression. Stat Comput (2014) 1.08
Keratin variants are overrepresented in primary biliary cirrhosis and associate with disease severity. Hepatology (2009) 1.08
Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis. Gut (2005) 1.07
The diagnosis of primary biliary cirrhosis. Autoimmun Rev (2014) 1.03
Primary biliary cirrhosis: Pathophysiology, clinical presentation and therapy. World J Hepatol (2015) 0.99
Serum Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein Level Predicts Liver Fibrosis and Prognosis in Primary Biliary Cirrhosis. Am J Gastroenterol (2015) 0.97
Transplantation in autoimmune liver diseases. World J Gastroenterol (2008) 0.94
Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis. J Clin Immunol (2007) 0.93
Assessment of liver function in primary biliary cirrhosis using Gd-EOB-DTPA-enhanced liver MRI. HPB (Oxford) (2010) 0.93
Hepatic phosphorus-31 magnetic resonance spectroscopy in primary biliary cirrhosis and its relation to prognostic models. Gut (1996) 0.92
Liver transplantation--challenges for the future. West J Med (1991) 0.92
Prognostic value of generation of growth hormone-stimulated insulin-like growth factor-I (IGF-I) and its binding protein-3 in patients with compensated and decompensated liver cirrhosis. Dig Dis Sci (1998) 0.92
Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis. Gut (2005) 0.91
Autoantibodies to GW bodies and other autoantigens in primary biliary cirrhosis. Clin Exp Immunol (2010) 0.90
Evolution of the Food and Drug Administration approach to liver safety assessment for new drugs: current status and challenges. Drug Saf (2014) 0.89
Serum interferon-gamma-inducing factor/IL-18 levels in primary biliary cirrhosis. Clin Exp Immunol (2000) 0.89
A simulation modelling approach to evaluating alternative policies for the management of the waiting list for liver transplantation. Health Care Manag Sci (2001) 0.89
Liver Transplantation for Cholestatic Liver Diseases in Adults. Clin Liver Dis (2015) 0.88
Risk factors for hepatic decompensation in patients with primary biliary cirrhosis. World J Gastroenterol (2013) 0.86
Graphical procedures for evaluating overall and subject-specific incremental values from new predictors with censored event time data. Biometrics (2011) 0.86
The overlap syndromes of autoimmune hepatitis. Dig Dis Sci (2012) 0.86
Survival data analysis with time-dependent covariates using generalized additive models. Comput Math Methods Med (2012) 0.85
Network meta-analysis of randomized controlled trials: efficacy and safety of UDCA-based therapies in primary biliary cirrhosis. Medicine (Baltimore) (2015) 0.85
Indications for referral and assessment in adult liver transplantation: a clinical guideline. British Society of Gastroenterology. Gut (1999) 0.85
Clinical features and management of primary biliary cirrhosis. World J Gastroenterol (2008) 0.85
Inverse probability weighting for covariate adjustment in randomized studies. Stat Med (2013) 0.85
Liver physiology and liver diseases in the elderly. World J Gastroenterol (2013) 0.84
Characterisation of patients with a complete biochemical response to ursodeoxycholic acid. Gut (1995) 0.84
Liver/spleen volume ratio as a predictor of prognosis in primary biliary cirrhosis. J Gastroenterol (2008) 0.83
Liver Transplantation for Patients with Cholestatic Liver Diseases. Viszeralmedizin (2015) 0.83
Prognostic indicators in primary biliary cirrhosis: significance of revised IAHG (International Autoimmune Hepatitis Group) score. Clin Mol Hepatol (2012) 0.83
Interstitial lung disease and Sjögren's syndrome in primary biliary cirrhosis: a causal or casual association? Clin Rheumatol (2008) 0.82
Evaluating interventions for Ebola: The need for randomized trials. Clin Trials (2016) 0.82
Primary biliary cirrhosis: new perspectives in diagnosis and treatment. Postgrad Med J (2000) 0.82
On Sparse Estimation for Semiparametric Linear Transformation Models. J Multivar Anal (2010) 0.81
A Tutorial on Rank-based Coefficient Estimation for Censored Data in Small- and Large-Scale Problems. Stat Comput (2013) 0.80
Increased granulysin expression in peripheral blood cells of patients with primary biliary cirrhosis and its clinical implications. J Clin Immunol (2008) 0.80
Survival of anti-mitochondrial antibody-positive and -negative primary biliary cirrhosis patients on ursodeoxycholic acid treatment. Dig Dis Sci (2004) 0.80
Anti-M4 antibodies measured by a sulphite oxidase ELISA in patients with both anti-centromere and anti-M2 antibodies. Clin Exp Immunol (1995) 0.79
Hepatic retransplantation in cholestatic liver disease: impact of the interval to retransplantation on survival and resource utilization. Hepatology (1999) 0.78
The ursodeoxycholic acid story in primary biliary cirrhosis. Gut (1995) 0.78
Genomic variants associated with primary biliary cirrhosis. Genome Med (2010) 0.78
Ursodeoxycholic acid improves bilirubin but not albumin in primary biliary cirrhosis: further evidence for nonefficacy. Biomed Res Int (2013) 0.77
Antipyrine clearance and metabolite formation in primary biliary cirrhosis. Dig Dis Sci (2001) 0.77
Mortality rate of patients with asymptomatic primary biliary cirrhosis diagnosed at age 55 years or older is similar to that of the general population. J Gastroenterol (2009) 0.77
Trends in liver transplantation for primary biliary cirrhosis in the Netherlands 1988-2008. BMC Gastroenterol (2010) 0.77
Liver transplantation(). J Ultrasound (2007) 0.77
High levels of FCγR3A and PRF1 expression in peripheral blood mononuclear cells from patients with primary biliary cirrhosis. Dig Dis Sci (2012) 0.77
Moexipril for treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid. Dig Dis Sci (2009) 0.76
Optimal drug regimens for primary biliary cirrhosis: a systematic review and network meta-analysis. Oncotarget (2015) 0.76
Waiting list mortality of patients with primary biliary cirrhosis in the Japanese transplant allocation system. J Gastroenterol (2013) 0.76
Prognostic factors and survival analysis of antimitochondrial antibody-positive primary biliary cirrhosis in Chinese patients. Dig Dis Sci (2011) 0.76
Primary Biliary Cholangitis: Disease Pathogenesis and Implications for Established and Novel Therapeutics. J Clin Exp Hepatol (2016) 0.75
Translation and validation of the Serbian primary biliary cholangitis-40 questionnaire. PLoS One (2017) 0.75
Primary biliary cirrhosis. Gut (1991) 0.75
Prediction of oesophageal varices in patients with primary biliary cirrhosis by non-invasive markers. Arch Med Sci (2017) 0.75
Primary biliary cirrhosis and liver transplantation. Intractable Rare Dis Res (2012) 0.75
Prognosis in PBC: who should we believe? Hepatology (1990) 0.75
Current advances in liver transplantation. Ochsner J (1999) 0.75
Sparse estimation of Cox proportional hazards models via approximated information criteria. Biometrics (2016) 0.75
Primary biliary cirrhosis: Clinical and laboratory criteria for its diagnosis. World J Gastroenterol (2015) 0.75
Immunosuppressive therapy in immune-mediated liver disease in the non-transplanted patient. Pharmaceuticals (Basel) (2013) 0.75
Failure time regression with continuous informative auxiliary covariates. J Stat Distrib Appl (2015) 0.75
ANALYSIS OF DEPENDENTLY CENSORED DATA BASED ON QUANTILE REGRESSION. Stat Sin (2014) 0.75
Liver transplantation. Gut (1991) 0.75
High concentration of antimitochondrial antibodies predicts progressive primary biliary cirrhosis. World J Gastroenterol (2005) 0.75
Checking Fine and Gray subdistribution hazards model with cumulative sums of residuals. Lifetime Data Anal (2014) 0.75
Circulating FGF19 closely correlates with bile acid synthesis and cholestasis in patients with primary biliary cirrhosis. PLoS One (2017) 0.75
Impact of comorbidity on waiting list and post-transplant outcomes in patients undergoing liver retransplantation. World J Hepatol (2017) 0.75
A risk-based measure of time-varying prognostic discrimination for survival models. Biometrics (2016) 0.75
A brief review on prognostic models of primary biliary cholangitis. Hepatol Int (2017) 0.75
A multiple testing procedure for clinical trials. Biometrics (1979) 26.80
Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med (1990) 11.57
Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet (1994) 11.37
Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med (2001) 7.69
Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes. JAMA (1992) 6.99
One-sample multiple testing procedure for phase II clinical trials. Biometrics (1982) 6.45
Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med (1990) 6.43
Aneurysmal coronary artery disease. Circulation (1983) 5.58
An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA (1993) 5.43
Estimating the proportion of treatment effect explained by a surrogate marker. Stat Med (1997) 4.64
An influenza simulation model for immunization studies. Am J Epidemiol (1976) 4.12
Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic. J Clin Oncol (1989) 4.03
Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation (1983) 3.99
Comparative reliability and validity of chronic pain intensity measures. Pain (1999) 3.92
Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Intern Med (1995) 3.83
Designs for group sequential tests. Control Clin Trials (1984) 3.56
High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison. N Engl J Med (1985) 3.36
Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group. Ann Intern Med (1998) 2.95
Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med (1993) 2.91
Blacks in the coronary artery surgery study (CASS): race and clinical decision making. Am J Public Health (1986) 2.56
Weighted Kaplan-Meier statistics: a class of distance tests for censored survival data. Biometrics (1989) 2.51
A prospective study of work perceptions and psychosocial factors affecting the report of back injury. Spine (Phila Pa 1976) (1991) 2.48
Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N Engl J Med (1989) 2.42
1995 Volvo Award in clinical sciences. Determinants of lumbar disc degeneration. A study relating lifetime exposures and magnetic resonance imaging findings in identical twins. Spine (Phila Pa 1976) (1995) 2.40
Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology (1989) 2.39
Clinical and angiographic predictors of operative mortality from the collaborative study in coronary artery surgery (CASS). Circulation (1981) 2.27
Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study. J Clin Oncol (1995) 2.26
Cytomegalovirus excretion as a predictor of cytomegalovirus disease after marrow transplantation: importance of cytomegalovirus viremia. J Infect Dis (1990) 2.25
Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol (1988) 2.24
Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease. JAMA (1999) 2.21
Diagnostic plots to reveal functional form for covariates in multiplicative intensity models. Biometrics (1995) 2.19
Cyclophosphamide plus cis-platinum in combination: treatment program for stage III or IV ovarian carcinoma. Obstet Gynecol (1982) 2.12
Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens. Blood (1990) 2.09
Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer. J Clin Oncol (1995) 2.02
Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. Blood (1994) 1.98
Myocardial infarction in young adults: angiographic characterization, risk factors and prognosis (Coronary Artery Surgery Study Registry). J Am Coll Cardiol (1995) 1.94
Efficiency of liver transplantation in patients with primary biliary cirrhosis. N Engl J Med (1989) 1.94
Prognostic importance of a clinical profile and exercise test in medically treated patients with coronary artery disease. J Am Coll Cardiol (1984) 1.91
Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation (1994) 1.86
Marital quality, marital disruption, and immune function. Psychosom Med (1987) 1.81
The sudden infant death syndrome: repetitions in families. J Pediatr (1980) 1.81
Mortality hazard functions as related to neutropenia at different times after marrow transplantation. Blood (1996) 1.81
Exercise stress testing. Correlations among history of angina, ST-segment response and prevalence of coronary-artery disease in the Coronary Artery Surgery Study (CASS). N Engl J Med (1979) 1.79
Survival of medically treated patients in the coronary artery surgery study (CASS) registry. Circulation (1982) 1.79
Diminished survival in asymptomatic primary biliary cirrhosis. A prospective study. Gastroenterology (1990) 1.76
Effect of completeness of revascularization on long-term outcome of patients with three-vessel disease undergoing coronary artery bypass surgery. A report from the Coronary Artery Surgery Study (CASS) Registry. Circulation (1992) 1.75
Effect of coronary bypass surgery on survival patterns in subsets of patients with left main coronary artery disease. Report of the Collaborative Study in Coronary Artery Surgery (CASS). Am J Cardiol (1981) 1.74
Prognostic value of angiographic indices of coronary artery disease from the Coronary Artery Surgery Study (CASS). J Clin Invest (1983) 1.70
Five-year angiographic follow-up of factors associated with progression of coronary artery disease in the Coronary Artery Surgery Study (CASS). CASS Participating Investigators and Staff. J Am Coll Cardiol (1993) 1.66
Isometric lifting strength as a predictor of industrial back pain reports. Spine (Phila Pa 1976) (1989) 1.63
Cytomegalovirus (CMV)-specific intravenous immunoglobulin for the prevention of primary CMV infection and disease after marrow transplant. J Infect Dis (1991) 1.62
Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: a randomized trial of two irradiation regimens. Blood (1991) 1.61
Blacks in the Coronary Artery Surgery Study: risk factors and coronary artery disease. Circulation (1986) 1.59
Safety and toxicity of nonoxynol-9 gel as a rectal microbicide. Sex Transm Dis (1999) 1.58
Hepatic toxicity associated with fluorouracil plus levamisole adjuvant therapy. J Clin Oncol (1993) 1.52
Ten-year follow-up of quality of life in patients randomized to receive medical therapy or coronary artery bypass graft surgery. The Coronary Artery Surgery Study (CASS) Circulation (1990) 1.51
Primary sclerosing cholangitis: refinement and validation of survival models. Gastroenterology (1992) 1.51
Prognosis for central vision and anatomic reattachment in rhegmatogenous retinal detachment with macula detached. Am J Ophthalmol (1981) 1.49
Graft-rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics. Bone Marrow Transplant (1995) 1.47
A clinical trial of amygdalin (Laetrile) in the treatment of human cancer. N Engl J Med (1982) 1.47
Effects of smoking on survival and morbidity in patients randomized to medical or surgical therapy in the Coronary Artery Surgery Study (CASS): 10-year follow-up. CASS Investigators. J Am Coll Cardiol (1992) 1.45
Crossovers in coronary artery bypass grafting trials: desirable, undesirable, or both? Ann Thorac Surg (1989) 1.44
Predictors of completed suicide in a cohort of 50,465 young men: role of personality and deviant behaviour. BMJ (1988) 1.44
Policies for study monitoring and interim reporting of results. J Clin Oncol (1987) 1.41
Assessment of pain during medical procedures: a comparison of three scales. Clin J Pain (1998) 1.41
Pulmonary resection for metastatic nonosteogenic sarcoma. Cancer (1979) 1.34
Postnatal growth and the sudden infant death syndrome. Am J Epidemiol (1974) 1.33
Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: the 21-year Seattle experience. J Clin Oncol (1993) 1.32
Comparison of operative mortality and morbidity for initial and repeat coronary artery bypass grafting: The Coronary Artery Surgery Study (CASS) registry experience. Ann Thorac Surg (1984) 1.31
Magnetic resonance imaging findings and their relationships in the thoracic and lumbar spine. Insights into the etiopathogenesis of spinal degeneration. Spine (Phila Pa 1976) (1995) 1.31
A controlled evaluation of recent approaches to biochemical modulation or enhancement of 5-fluorouracil therapy in colorectal carcinoma. J Clin Oncol (1985) 1.29
Association of sex, physical size, and operative mortality after coronary artery bypass in the Coronary Artery Surgery Study (CASS). J Thorac Cardiovasc Surg (1982) 1.27
Multivariate discriminant analysis of the clinical and angiographic predictors of operative mortality from the Collaborative Study in Coronary Artery Surgery (CASS). J Thorac Cardiovasc Surg (1980) 1.26
Simulation as a design tool for phase I/II clinical trials: an example from bone marrow transplantation. Control Clin Trials (1994) 1.25
Medical versus early surgical therapy in patients with triple-vessel disease and mild angina pectoris: a CASS registry study of survival. Ann Thorac Surg (1987) 1.24
Idiopathic dilated cardiomyopathy in the young: clinical profile and natural history. J Am Coll Cardiol (1985) 1.24
Reproducibility of coronary arteriographic reading in the coronary artery surgery study (CASS). Cathet Cardiovasc Diagn (1982) 1.24
Adjuvant chemotherapy with 5-FU, adriamycin, and mitomycin-C (FAM) versus surgery alone for patients with locally advanced gastric adenocarcinoma: A Southwest Oncology Group study. Ann Surg Oncol (1995) 1.23
The effect of medical and surgical treatment on subsequent sudden cardiac death in patients with coronary artery disease: a report from the Coronary Artery Surgery Study. Circulation (1986) 1.21
Primary biliary cirrhosis: prediction of short-term survival based on repeated patient visits. Hepatology (1994) 1.21
Clinical features and analysis of risk factors for invasive candidal infection after marrow transplantation. J Infect Dis (1991) 1.18
Long-term fate of bypass grafts: the Coronary Artery Surgery Study (CASS) and Montreal Heart Institute experiences. Circulation (1985) 1.17
A longitudinal, prospective study of industrial back injury reporting. Clin Orthop Relat Res (1992) 1.16
Bundle branch block in patients with chronic coronary artery disease: angiographic correlates and prognostic significance. J Am Coll Cardiol (1987) 1.15
Similarities in degenerative findings on magnetic resonance images of the lumbar spines of identical twins. J Bone Joint Surg Am (1995) 1.14
Symmetric group sequential test designs. Biometrics (1989) 1.13
Observer variability in the assessment of disc degeneration on magnetic resonance images of the lumbar and thoracic spine. Spine (Phila Pa 1976) (1995) 1.12
Evidence for entry of plasma insulin into cerebrospinal fluid through an intermediate compartment in dogs. Quantitative aspects and implications for transport. J Clin Invest (1991) 1.12
Survival of black persons compared with white persons in the Coronary Artery Surgery Study (CASS). Am J Cardiol (1987) 1.12
Seattle Heart Watch: initial clinical, circulatory and electrocardiographic responses to maximal exercise. Am J Cardiol (1974) 1.11
Influence of positive lymphocyte crossmatch and HLA mismatching on vanishing bile duct syndrome in human liver allografts. Transplantation (1988) 1.10
Prospective evaluation of esophageal varices in primary biliary cirrhosis: development, natural history, and influence on survival. Gastroenterology (1989) 1.08
Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome. Blood (1993) 1.05
Considerations for monitoring and evaluating treatment effects in clinical trials. Control Clin Trials (1984) 1.05
Magnetic resonance imaging as a surrogate outcome for multiple sclerosis relapses. Mult Scler (2008) 1.04